These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7434380)

  • 1. The radioprotective effect of misonidazole (Ro-07-0582) on normal canine rectum.
    Stryker JA; Albert A; Abt AB
    Strahlentherapie; 1980; 156(10):719-24. PubMed ID: 7434380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradioprotection of the rat parotid gland by combined use of WR-2721 and Ro-07-0582.
    Sodicoff M; Conger AD; Pratt NE; Sinesi M; Trepper P
    Radiat Res; 1979 Nov; 80(2):348-53. PubMed ID: 228341
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK; Hurst S; Begg AC; Brown JM
    Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
    Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
    Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N; Persky L
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude mice.
    Rofstad EK; Brustad T
    Br J Radiol; 1979 May; 52(617):393-7. PubMed ID: 444837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and anti-tumor studies with the radiosensitizer misonidazole in dogs with spontaneous fibrosarcomas.
    Creasey WA; Thrall DE
    Am J Vet Res; 1982 Jun; 43(6):1015-8. PubMed ID: 7103170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of misonidazole therapy on human granulopoietic stem cells.
    Allalunis MJ; Turner AR; Partington JP; Urtasun RC
    Cancer Treat Rep; 1980; 64(10-11):1097-102. PubMed ID: 7459895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ; Sigdestad CP; Jovonovich JA
    Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of misonidazole on some physiologic parameters in mice.
    Conroy PJ; von Burg R; Passalacqua W; Sutherland RM
    J Pharmacol Exp Ther; 1980 Jan; 212(1):47-52. PubMed ID: 7351625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of excision repair on the mutagenesis of misonidazole.
    Kacinski BM; Mroczkowski Z; Rupp WD
    Cancer Clin Trials; 1980; 3(1):69-71. PubMed ID: 6993036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of misonidazole.
    Notter G; Rylander U; Turesson I
    Strahlentherapie; 1980; 156(10):714-8. PubMed ID: 7434379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats.
    Trajković S; Dobrić S; Jaćević V; Dragojević-Simić V; Milovanović Z; Dordević A
    Colloids Surf B Biointerfaces; 2007 Jul; 58(1):39-43. PubMed ID: 17317115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
    Kleine W; Stange S; Nagy D; Ladner HA
    Strahlentherapie; 1982 Aug; 158(8):498-503. PubMed ID: 6814020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined radiation-protective and radiation-sensitizing agents: II. Radiosensitivity of hypoxic or aerobic Chinese hamster fibroblasts in the presence of cysteamine and misonidazole: implications for the "oxygen effect" (with appendix on calculation of dose-modifying factors).
    Koch CJ; Howell RL
    Radiat Res; 1981 Aug; 87(2):265-83. PubMed ID: 7267995
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
    Grigsby P; Maruyama Y
    Br J Radiol; 1981 Nov; 54(647):969-72. PubMed ID: 6272925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of size of lymph node metastases on the radiation response: influence of misonidazole.
    Courdi A; Malaise EP
    Radiat Res; 1980 Sep; 83(3):723-31. PubMed ID: 7413932
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo.
    Denekamp J; Michael BD; Harris SR
    Radiat Res; 1974 Oct; 60(1):119-32. PubMed ID: 10881705
    [No Abstract]   [Full Text] [Related]  

  • 19. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy.
    Kouvaris J; Kouloulias V; Malas E; Antypas C; Kokakis J; Michopoulos S; Matsopoulos G; Vlahos L
    Strahlenther Onkol; 2003 Mar; 179(3):167-74. PubMed ID: 12627259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of misonidazole on the incidence of radiation-induced intestinal tumours in mice.
    Rostom AY; Kauffman SL; Steel GG
    Br J Cancer; 1978 Oct; 38(4):530-6. PubMed ID: 728340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.